UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000025856
Receipt No. R000029698
Scientific Title Phase 1 study to evaluate the safety of dasatinib in relapsed and refractory angioimmunoblastic T-cell lymphoma
Date of disclosure of the study information 2017/01/30
Last modified on 2018/07/31 13:07:42

No. Disposal Last modified on Item of update
1 Insert 2017/01/26 13:59:52
2 Update 2017/07/14 16:55:11 Recruitment status
3 Update 2018/07/31 13:07:42 Recruitment status
Anticipated trial start date
Last follow-up date


Contact us.